Patents expiring in 2029

US 7560471

Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents

Laboratories Almirall, S.A. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560469

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560466

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7560440

Regulation of angiogenesis with zinc finger proteins

Sangamo Biosciences, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563459

Methods and compositions for regenerating tissue

The United States of America as represented by the Department of Vetrans Affairs · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563593

Method for preparing cell cultures from biological specimens for assaying secreted factors

Precision Therapeutics, Inc. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563795

Phenyl-piperazine derivatives as modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563930

Crystal forms of Cinacalcet HCI and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563446

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563457

Nanoparticle assembled hollow spheres

The Regents of the University of California · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563777

Method to induce neovascular formation and tissue regeneration

Fundacion Universitaria Dr. Rene G. Favaloro · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563585

Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563596

Method of modulating tissue growth using Frzb protein

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563766

Methods and compositions for the promotion of a hair growth utilizing actin binding peptides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563892

Prodrugs of 2,4 pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563874

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563918

Solid and crystalline ibandronate sodium and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563920

Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile)copper(I) tetrafluoroborate

Draximage Limited · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7563883

Recombinant P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566719

Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566462

Stable tablet formulation

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566451

Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566447

Biocides

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566552

Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors

CropDesign N.V. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566465

Artemisinins in the clinical and veterinary management of kinetoplastid infections

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566540

Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566785

Amidine substituted aryl aniline compounds

Theravance, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566714

Methods and compositions for the treatment of metabolic disorders

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566718

Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7566732

Rhodanine compositions for use as antiviral agents

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569604

Heterocyclic derivatives for modulation of calcium channels

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569673

Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569542

Anti-microbial targeting chimeric pharmaceutical

The Regents of the University of California · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569340

Nanoarrays of single virus particles, methods and instrumentation for the fabrication and use thereof

Northwestern University · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569697

Benzimidazole compound crystal

Takeda Pharmaceutical Company Limited · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569214

Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

Nektar Therapeutics AL, Corporation · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569386

Chondroitin synthase gene and methods of making and using same

The Board of Regents of the University of Oklahoma · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569570

Thienopyrimidines, process for preparing the same and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569580

Heterotricyclic compounds for use as HCV inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569586

Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity

Theravance, Inc. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569588

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569591

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569729

Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability

Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569683

UspA2 nucleic acid of Moraxella catarrhalis

The Board of Regents of the University of Texas System · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7569696

Process for producing crystal

Takeda Pharmaceutical Company Limited · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572124

Apparatus for simultaneous illumination of teeth

DISCUS DENTAL, LLC · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572891

Kidney-specific tumor vaccine directed against kidney tumor antigen G-250

The Regents of the University of California · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7572828

Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)